Skip to main navigation Skip to search Skip to main content

Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics

Hengde Li (Co-first Author), Shuai Zha* (Co-first Author), Haolan Li, Haitao Liu, Ka-Leung Wong*, Angelo H. All*

*Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Dendrimers are polymers with well-defined 3D branched structures that are vastly utilized in various neurotheranostics and biomedical applications, particularly as nanocarrier vectors. Imaging agents can be loaded into dendrimers to improve the accuracy of diagnostic imaging processes. Likewise, combining pharmaceutical agents and anticancer drugs with dendrimers can enhance their solubility, biocompatibility, and efficiency. Practically, by modifying ligands on the surface of dendrimers, effective therapeutic and diagnostic platforms can be constructed and implemented for targeted delivery. Dendrimer-based nanocarriers also show great potential in gene delivery. Since enzymes can degrade genetic materials during their blood circulation, dendrimers exhibit promising packaging and delivery alternatives, particularly for central nervous system (CNS) treatments. The DNA and RNA encapsulated in dendrimers represented by polyamidoamine that are used for targeted brain delivery, via chemical-structural adjustments and appropriate generation, significantly improve the correlation between transfection efficiency and cytotoxicity. This article reports a comprehensive review of dendrimers’ structures, synthesis processes, and biological applications. Recent progress in diagnostic imaging processes and therapeutic applications for cancers and other CNS diseases are presented. Potential challenges and future directions in the development of dendrimers, which provide the theoretical basis for their broader applications in healthcare, are also discussed. © 2022 Wiley-VCH GmbH.
Original languageEnglish
Article number2203629
Number of pages21
JournalSmall
Volume18
Issue number45
Online published9 Sept 2022
DOIs
Publication statusPublished - 10 Nov 2022
Externally publishedYes

Funding

H.L. and S.Z. contributed equally to this work. The authors would like to thank Nga Hei Wong and Yim Hing Kwok for their limited contribution in drafting this manuscript. This study was supported by the Hong Kong Baptist University: Start‐Up Tier 1 Fund # 21.4531.162640 (PI: A.H.A.), Faculty Seed Fund # 31.4531.179234 (PI: A.H.A.), Initiation Grant for Faculty Niche Research Areas (IG‐FNRA) 2020/21 (PI: A.H.A.), and Research Grant Council General Research Fund (GRF) 2021–22 (PI: A.H.A.).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • dendrimers
  • drug delivery
  • gene delivery
  • imaging agent carriers
  • neurotheranostics
  • nonviral vectors
  • polymers

RGC Funding Information

  • RGC-funded

Fingerprint

Dive into the research topics of 'Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics'. Together they form a unique fingerprint.

Cite this